The WHO Essential Medicines List (EML) is an important tool in global health and supports the achievement of the UN Sustainable Development Goals. IFPMA has published perspectives from the R&D-based industry on the utility and scope of the EML. This position paper represents IFPMA's perspective as of April 2023, ahead of the publication of the revised version of the EML.
Read moreOn 1 February 2023, IPSF submitted a statement delivered on behalf of IPSF, IAPO, and IFPMA for the WHO EB152 agenda item related to substandard and falsified medical products.
Read moreThe transfer of advanced technology is essential for economic development. It enables countries to accelerate the acquisition of knowledge, experience and equipment related to advanced, innovative industrial products and processes. This, in turn, builds the skills of the local workforce and creates new high-tech employment opportunities.
Read more